Atlas Trials

Phase 1 Study of AlphaMedix™ in Adult Subjects With SSTR (+) NET

Clinical trial NCT03466216 · TERMINATED

Trial details

NCT number
NCT03466216
Sponsor
Orano Med LLC
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Neuroendocrine Tumor
Start date
2018-02-05
Primary completion
2023-04-06
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.